Skip to main navigation Skip to search Skip to main content

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

  • The SPIN MTX Consensus Survey Study Group
  • University of Amsterdam
  • Onze Lieve Vrouwe Gasthuis
  • University of Pecs
  • Arhus Universitetshospital
  • Salford Royal Hospital Foundation Trust
  • Centro Dermatológico Schejtman
  • Bispebjerg Hospital
  • Tehran University of Medical Sciences
  • Apollo Hospitals Group
  • University of Auckland
  • Universidade Federal de Minas Gerais
  • Military Teaching Hospital Begin
  • University of Split Medical School
  • Akdeniz University
  • University Medical Center Groningen
  • Teaching Hospital Kaposvar
  • Universidad de Costa Rica
  • Psoriasis Treatment Wards
  • Universidad Austral
  • Hospital Universitari Germans Trias i Pujol
  • Dermatology Service of La Samaritana University Hospital
  • San Ignacio University Hospital and Scientific
  • Proderma
  • Hospital Lyon-Sud Lyon University
  • Centro Dermatologico Dr. Ladislao De La Pascua
  • Vancouver General Hospital, The Prostate Centre, University of British Columbia, Faculty of Medicine
  • Instituto de Rehabilitación Psicofísica
  • Clínica Dermacross
  • Centre Hospitalier Universitaire Vaudois
  • University Hospital Centre Zagreb
  • Hopital Edouard Herriot
  • Department of Neurology
  • CHA University
  • Al-Azhar Faculty of Medicine
  • Geneva University Hospitals
  • Hôpital Victor Dupouy
  • Uppsala University
  • Hospital Vargas de Caracas
  • Universitat Autònoma de Barcelona 
  • Université Libre de Bruxelles, Erasme Academic Hospital
  • Guy's and St Thomas' NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

Abstract

Importance: A clear dosing regimen for methotrexate in psoriasis is lacking, and this might lead to a suboptimal treatment. Because methotrexate is affordable and globally available, a uniform dosing regimen could potentially optimize the treatment of patients with psoriasis worldwide. Objective: To reach international consensus among psoriasis experts on a uniform dosing regimen for treatment with methotrexate in adult and pediatric patients with psoriasis and identify potential future research topics. Design, Setting, and Participants: Between September 2020 and March 2021, a survey study with a modified eDelphi procedure that was developed and distributed by the Amsterdam University Medical Center and completed by 180 participants worldwide (55 [30.6%] resided in non-Western countries) was conducted in 3 rounds. The proposals on which no consensus was reached were discussed in a conference meeting (June 2021). Participants voted on 21 proposals with a 9-point scale (1-3 disagree, 4-6 neither agree nor disagree, 7-9 agree) and were recruited through the Skin Inflammation and Psoriasis International Network and European Academy of Dermatology and Venereology in June 2020. Apart from being a dermatologist/dermatology resident, there were no specific criteria for participation in the survey. The participants worked mainly at a university hospital (97 [53.9%]) and were experienced in treating patients with psoriasis with methotrexate (163 [91.6%] had more than 10 years of experience). Main Outcomes and Measures: In a survey with eDelphi procedure, we tried to reach consensus on 21 proposals. Consensus was defined as less than 15% voting disagree (1-3). For the consensus meeting, consensus was defined as less than 30% voting disagree. Results: Of 251 participants, 180 (71.7%) completed all 3 survey rounds, and 58 participants (23.1%) joined the conference meeting. Consensus was achieved on 11 proposals in round 1, 3 proposals in round 2, and 2 proposals in round 3. In the consensus meeting, consensus was achieved on 4 proposals. More research is needed, especially for the proposals on folic acid and the dosing of methotrexate for treating subpopulations such as children and vulnerable patients. Conclusions and Relevance: In this eDelphi consensus study, consensus was reached on 20 of 21 proposals involving methotrexate dosing in patients with psoriasis. This consensus may potentially be used to harmonize the treatment with methotrexate in patients with psoriasis.

Original languageEnglish
Pages (from-to)561-572
Number of pages12
JournalJAMA dermatology
Volume158
Issue number5
DOIs
Publication statusPublished - May 2022

Fingerprint

Dive into the research topics of 'International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis'. Together they form a unique fingerprint.

Cite this